Hinge Health, Inc. (HNGE) stock
Close on Nov 17, 2026Market cap $9.23BP/E –Yield –
Hinge Health, Inc. grew revenue 49.8% to $720.06M over the twelve months to Jun 30, 2026. Free cash flow was $290.12M, up 218.2% from a year earlier. At the latest close the market valued the company at $9.23B.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $9.23B
- P/E ratio
- –
- Price to sales
- 12.82
- Price to book
- 26.81
- Dividend yield
- –
- Free cash flow yield
- 3.14%
Fundamentals
- Revenue
- $720.06M
- Net income
- $109.07M
- EPS, diluted
- -$7.77
- Free cash flow
- $290.12M
- Book value per share
- $4.13
- Diluted shares
- 83M
Trading
- Next earnings
- Feb 9, 2027 (estimated, after the close)
- Previous close
- $121.29
- Open
- $120.90
- Day's range
- $113.11 – $121.18
- Volume
- 1,744,753
- Average volume (20 days)
- 1,959,556
- Index membership
- Russell 2000 (since Jun 2026), Russell 3000
- 52-week range
- $30.08 – $126.40
- RSI (14 days)
- 51.6
- Volatility (1 year)
- 51.8%
- Relative volume
- 0.94×
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 17, 2026. The S&P 500 is measured by the SPY fund.
| Period | HNGE | S&P 500 | Difference | HNGE per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +15.4% | -4.0% | +19.4 pts | ||
| 3 months | +30.2% | -5.0% | +35.2 pts | ||
| Year to date | +146.3% | +8.2% | +138.1 pts | ||
| 1 year | +180.1% | +11.2% | +168.9 pts |
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Hinge Health filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Update
- Results
- Results
About Hinge Health
Services-Computer Processing & Data Preparation
Hinge Health operates a digital healthcare technology platform designed to automate and scale care for joint and muscle conditions. The company provides personalized care across the musculoskeletal health continuum, including injury prevention, acute pain management, chronic condition therapy, and pre- and post-surgical rehabilitation. Its platform integrates artificial intelligence-driven motion tracking, a proprietary wearable device for electrical nerve stimulation, and support from a care team of licensed physical therapists, physicians, and health coaches. The company also coordinates in-person care through a high-performance clinical provider network. Its customers primarily include self-insured employers across enterprise and public sectors, fully insured commercial health plans, Medicare Advantage populations, and federal insurance programs.
Company profile, executives and historyHinge Health stock: common questions
What is Hinge Health's stock price?
HNGE closed at $114.41 on Nov 17, 2026, down 5.67% on the day. Over the past 52 weeks it traded between $30.08 and $126.40.
What is Hinge Health's market cap?
Hinge Health was worth $9.23B at the close on Nov 17, 2026: the share price times the diluted shares outstanding.
What is HNGE's P/E ratio?
Hinge Health lost money over fiscal 2025 (diluted EPS -$7.77), so it has no meaningful P/E ratio.
How much revenue does Hinge Health make?
Hinge Health reported revenue of $720.06M for the twelve months to Jun 30, 2026, up 49.8% from a year earlier.
Does Hinge Health pay a dividend?
No. Hinge Health has not paid a cash dividend over the last twelve months.
When does Hinge Health report earnings next?
Hinge Health is expected to report Q4 FY2026 results on Feb 9, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has HNGE stock performed over the past year?
Including dividends, HNGE returned +180.1% over the past year, against +11.2% for the S&P 500.
How many HNGE shares are sold short?
5M shares were sold short at the latest FINRA report, 12.24% of the float, or 2.4 days of average trading volume.
Who are Hinge Health's competitors?
Companies most similar to Hinge Health by business, industry and size include GDRX, PD, SSTK, INOD, EGHT.
See a number that looks wrong?